P2 and P4 are temperate phages that infect Escheof viable phages as well as the tolerance of amino acid replacements in the region between h2 and N* for virus richia coli (1) . P4 lacks the genetic information for its structural proteins and relies upon its ability to control production. Tolerance of amino acid replacements in this portion of the N protein might be exploited for peptide the late genes of P2, its helper (2, 3), which codes for the head and tail proteins. P4 encodes, however, a cappresentation by P4 (10, 11) .
To test the ability of N* to complement gpN in making sid-size determination protein called Sid. This protein directs the formation of the P4 capsid (T Å 4), which is infectious P2 and P4 particles, burst-size experiments were performed with a temperature sensitive P2 N musmaller than that of phage P2 (T Å 7) (4). The P4 capsid fits the 11.6-kbp genome of P4, while the P2 capsid actant (P2 sir22, nonpermissive temperature is 37Њ, provided by E. Six) . The N*-protein was also tested for its commodates the 33.8-kbp P2 genome (5) . The capsid protein gpN (357 aa), which we focus on in this communiability to complement P4 particle formation, monitored in a P4-P2 sir22 coinfection. The N* part of the N gene was cation, is processed into three products: the major head protein N* (31 amino acids cleaved from the amino termicloned into a pBluescript II-vector and transformed into the standard host for P2 and P4 (E. coli C1-a (12)) for nal) and the minor head proteins h1 and h2, where 9 burst-size experiments. A full-length N gene clone was and 13 amino acids, respectively, are removed from the constructed in the same way as the N* clone and used amino terminal gpN ( Fig. 1) (6, 7) . The mature P2 capsid as control. In C1-a, N as well as N* show moderate consists of 420 N* subunits, whereas that of P4 contains constitutive expression from the lac promoter of the 20 h1 and 40 h2 in addition to 180 subunits of N* (7) . pBluescript vector (results not shown). The results of the The capsid assembly properties of N and N* have been complementation tests for P2 and P4 are shown in Table  analyzed in cells expressing a cloned N gene or a de-1. They demonstrate that N expression is able to compleleted version of the N gene giving rise to N* directly. In ment P2 sir22 at 37Њ as well as to sustain P4 growth, both cases P2-and P4-size procapsid structures were while N* expression fails to support either P2 sir22 or observed by electron microscopy (8, 9). This finding im-P4 growth. This result indicates that the 31-amino acid plies that the amino-terminal part (31 amino acids) of region preceding the cleavage site giving rise to N* is gpN is not required for assembly initiation (9). It was not essential for making infectious P2 as well as P4 particles. determined, however, whether N* was able to support As procapsid-like structures can assemble from N*-the formation of viable phage particles. In this communimonomers (9), it appears that the N-terminal part of gpN cation we test the ability of N* to support the formation is required during the postassembly maturation processes of the capsid rather than the initiation of procap-
1. An outline of the cleavage sites at the amino terminal part of gpN (7) and the c-myc sequence exchange between the h2 and N* cleavage sites.
N most likely occurs after prohead assembly. This is sence and presence of gpSid (supplied by infection with P4 vir1). Oligomeric structures were isolated from consistent with the observation that immature procapsids isolated from a mixed infection with P2 and P4 also the cell debris by differential centrifugation and purified by equilibrium centrifugation in a CsCl density contain full-length N (9).
To further investigate the dependence on the N-termigradient. The structures obtained from the N : : c-myc expressing cells were predominantly large aggrenal region of gpN in P2 and P4 particle maturation and to explore the possibility of using this region for peptide gates and aberrant unclosed shells, but there were also a fraction of closed shells of varying sizes ranging display by P4, a 33-bp replacement was made between the nucleotides corresponding to the h2 and N* cleavage from about 40 to 60 nm (Figs. 2A and 2B). The known dimensions of P2 and P4 procapsids, 55 and 40 nm, sites (see Fig. 1 ). This was done by site-specific mutagenesis according to Kunkel et al. (13) . The new amino respectively, fit within this size range. Hence, the result indicates that the N : : c-myc protein is able to form acid sequence corresponds to the first 10 amino acids of the human p62 c-myc protein followed by a proline closed procapsid-like structures of both P2 and P4 sizes, comparable to the structures obtained from the residue. This insertion results in a 10 amino acid c-myc epitope (EQKLISEEDL) that is specifically recognized by N or N* expressing cells (8, 9). In the case where N : : c-myc was expressed in the presence of gpSid, we the murine monoclonal antibody, c-myc Tag 1. The processing and assembly properties of N::c-myc as well as observed an increase in the number of closed shells with an average size of 40 -45 nm (Fig. 2B) . Hence, the ability to support the production of infectious P2 or P4 particles in complementation tests were studied in N : : c-myc appears to be able to respond to the sizedirecting effect of gpSid. As the processing of gpN is C1-a cells. The pBluescriptII/N::c-myc construction, denoted pKB3, is identical to the N-expressing clone pOM3 part of the capsid maturation, it was also of interest to determine whether N : : c-myc could be processed (8), except for the c-myc sequence. pOM3 was used as a control in all experiments.
into h1, h2, and N*. In order to investigate the extent of processing, the purified oligomeric structures of N : : cThe gpN : : c-myc protein was analyzed for its ability to assemble into procapsid-like structures in the abmyc (//0 gpSid) were immunodetected by polyclonal Note. Identical results were obtained when using E. coli XL1-Blue (13) as the host (results not shown). a The burst size is a measure of the number of phages produced per infected cell. (Burst size Å pfu observed/infective centers). Bacteria with the appropriate Bluescript clone were grown in 10 ml LB containing 50 mg/ml Amp, 0.11% glucose, 2.5 mM CaCl 2 at 30ЊC or 37ЊC to an optical density of 0.2 (Ç10 6 -10 7 cells/ml) at 600 nm. Cells were collected by centrifugation and the pellet was resuspended in 2 ml of ice cold LB including 5 mM CaCl 2 . Aliquots were plated to determine the cell count. 0.5 ml cells were transferred to a glass tube in a 37ЊC water bath for the complementation test and another at 30ЊC for the control. The cells were infected with P2 sir22 at a multiplicity of infection of 4-6 at t Å 0. Adsorption was allowed to proceed for 8 minutes, at which time P2-P4 antiserum was added to inactivate unabsorbed phages. The incubation was continued for 10 minutes and then aliquots were taken to measure infective centers. After 18 minutes, the culture was serially diluted 10 6 -10 7 fold into LB-containing glass tubes standing in the water bath, and incubation was continued. 90 minutes after infection, aliquots from different dilutions were plated to determine the phage yield. Burst sizes were calculated by dividing the total burst by the number of infective centers.
b A co-infection with P4 vir1 (15) and P2 sir22 was performed to measure the complementation ability of N* to make infectious P4. c Burst size of P2 sir22 was also measured in the co-infection experiment. antibodies against N* (Fig. 3, lanes 2 -4) . The novel must be either autocatalytic or host-dependent as no other P2 proteins are present under these experimenamino acid sequence between the h2 and N* cleavage sites does not seem to affect the processing of the tal conditions. The particle preparations were also analyzed for the presence of the c-myc epitope by mono-N : : c-myc protein, when compared to the processing observed in the mature P4 phage preparation (Fig. 3, clonal antibody Tag-1 after SDS -PAGE followed by blotting the proteins onto a filter. The filter with duplilane 1). As noted before (8), the processing of gpN cate samples was cut in two parts. The left part was formed as described for N*. Burst size results for P2 sir22 obtained from C1-a cells (Table 2) show that the N::canalyzed by polyclonal antibodies against N* (as already mentioned) and the right part by monoclonal myc clone (pKB3) fails to complement the tsN mutant phage P2 sir22 at nonpermissive temperature (37Њ), while antibodies against c-myc. The results in Fig. 3 demonstrate, as expected, that antibodies against c-myc the control (pOM3) complements P2 sir22 at the nonpermissive temperature. This result demonstrates that N::c-(lane 5 and 6) detect both full-length N : : c-myc and h1 : : c-myc/h2 : : c-myc proteins, but not N*. Surprismyc fusion protein is defective in supporting production of infectious P2 in C1-a. Due to the possibility of using ingly, full-length N : : c-myc protein was detected to a much lower extent compared to the strong detection the h1-h2 portion of gpN for peptide presentation by P4, it was of special interest to test whether N::c-myc could of h1 : : c-myc/h2 : : c-myc proteins, even though the amount of protein of N : : c-myc is larger than that of support growth of P4. Complementation tests were performed as described for N* by coinfecting P2 sir22 and h1 : : c-myc/h2 : : c-myc (see Lanes 2, 3, and 4). The access of monoclonal anti c-myc antibodies to the c-myc P4 vir1 in C1-a cells carrying the different N constructs.
The results in Table 2 show, however, that N::c-myc is epitope appears reduced. Since we can detect h1 : : cmyc and h2 : : c-myc proteins (we have not analyzed defective in sustaining P4 vir1 growth as well as production of infectious P2 sir22 phage particles. Thus, the them individually) with the antibodies, the extra amino acids in front of the h1-or h2-cleavage sites must be amino terminal part of the capsid protein N appears necessary to make infectious P2 and P4 virions. The N* responsible for the effect observed. This property has apparently no effect on the cleavage of gpN : : c-myc version is not able to support infectious particles even though N* can assemble into procapsid like particles (9) . protein.
To test whether N::c-myc can complement P2 sir22 N::c-myc can assemble into P2 and P4 sized procapsid structures and undergo processing, but the final maturaand sustain P4 growth, complementation tests were pertion process into infectious particles appears defective. In the case of N::c-myc, capsid maturation is blocked by the change of eight amino acids in the amino terminal part of N (see Fig. 1 ). N* and N::c-myc may block capsid maturation at different stages of the process. It is possible that the P2 capsid scaffold, gpO, normally interacts with the first 31 amino acids of gpN. gpO would then fail to function if the h1-h2 region is altered or gone. Another possible role for h1/h2 is to accommodate the portal protein gpQ in the initial assembly process and/or in DNA packaging. 
